NCT03997032View on ClinicalTrials.gov

A Study to Assess the Effect of a 3-month Folate Supplementation on Systemic Homocysteine Plasma Concentration and Ocular Blood Flow in Patients With Diabetes

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

March 12, 2018

Study Completion Date

July 17, 2018

Conditions
Diabetes
Interventions
DIETARY_SUPPLEMENT

Ocufolin

Ocufolin, Aprofol AG, Switzerland Dose: 1 capsule per day

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors
collaborator

Aprofol AG

UNKNOWN

lead

Medical University of Vienna

OTHER

NCT03997032 - A Study to Assess the Effect of a 3-month Folate Supplementation on Systemic Homocysteine Plasma Concentration and Ocular Blood Flow in Patients With Diabetes | Biotech Hunter | Biotech Hunter